PSNL
Personalis, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$13.34-13.32%
Price as of Jul 20, 2026
PSNL valuation
Personalis, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 14.67x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.48x
- Price / sales
- 21.65x
- Price / cash flow
- -17.58x
Enterprise value
- Enterprise value
- $1.2B
- EV / sales
- 18.64x
- EV / EBITDA
- -14.06x
- EV / EBIT
- -11.73x
- Market cap
- $1.4B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.